What is the link between gut microbial metabolites and colorectal cancer risk in inflammatory bowel disease?
In inflammatory bowel disease (IBD), chronic gut inflammation raises the risk of colorectal cancer (CRC). Gut microbial metabolites — chemicals produced by bacteria in the colon — play a dual role in this process. Some metabolites protect against cancer, while others actively promote it. Understanding this link may help develop new prevention strategies.
What the research says
A systematic review on colitis-associated colorectal cancer (CAC) — the type linked to IBD — found that gut microbial metabolites act through a 'metabolite-signaling pathway-epigenetics' network, with both protective and harmful effects 6. Protective metabolites include short-chain fatty acids (SCFAs), tryptophan derivatives like indole compounds, and vitamin B2. These reduce inflammation, strengthen the intestinal barrier, and suppress cancer pathways 6. In contrast, pathogenic metabolites such as secondary bile acids (e.g., deoxycholic acid), trimethylamine N-oxide (TMAO), and high levels of hydrogen sulfide promote cancer by activating inflammatory signals, damaging DNA, and disrupting immune balance 6. Elevated TMAO levels in the blood are linked to worse survival in CRC patients 6. Another review on gut microbiota and CRC notes that while specific microbes and their metabolites are implicated in carcinogenesis through genotoxic effects, inflammation, and immune dysregulation, it remains challenging to prove causation due to individual differences and the complexity of the microbiome 3. The gut microbiome's role in IBD and CRC is also highlighted in broader research, emphasizing that microbial imbalance (dysbiosis) can contribute to disease progression 9.
What to ask your doctor
- Could my IBD treatment plan include strategies to support protective gut metabolites, such as increasing short-chain fatty acids through diet or supplements?
- Are there any tests to measure my levels of harmful metabolites like secondary bile acids or TMAO, and would that change my care?
- What dietary changes might help reduce the risk of colorectal cancer given my IBD?
- Should I consider any specific probiotic or prebiotic therapies to balance my gut microbiome?
This question is drawn from common patient questions about Gastroenterology and answered using cited medical research. We do not provide individualized advice.